A detailed history of Heartwood Wealth Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Heartwood Wealth Advisors LLC holds 3,854 shares of AMGN stock, worth $1.22 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
3,854
Previous 3,772 2.17%
Holding current value
$1.22 Million
Previous $1.18 Million 5.35%
% of portfolio
0.14%
Previous 0.14%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$309.38 - $337.38 $25,369 - $27,665
82 Added 2.17%
3,854 $1.24 Million
Q2 2024

Jul 09, 2024

BUY
$262.75 - $319.31 $18,392 - $22,351
70 Added 1.89%
3,772 $1.18 Million
Q1 2024

Apr 02, 2024

SELL
$268.87 - $324.56 $23,929 - $28,885
-89 Reduced 2.35%
3,702 $1.05 Million
Q4 2023

Jan 17, 2024

SELL
$255.7 - $288.46 $255 - $288
-1 Reduced 0.03%
3,791 $1.09 Million
Q3 2023

Oct 17, 2023

SELL
$218.65 - $271.46 $72,154 - $89,581
-330 Reduced 8.01%
3,792 $1.02 Million
Q2 2023

Jul 19, 2023

BUY
$214.27 - $253.37 $142,061 - $167,984
663 Added 19.17%
4,122 $915,000
Q1 2023

Apr 14, 2023

BUY
$225.79 - $275.2 $107,927 - $131,545
478 Added 16.03%
3,459 $836,000
Q4 2022

Jan 12, 2023

SELL
$229.03 - $291.01 $76,496 - $97,197
-334 Reduced 10.08%
2,981 $0
Q3 2022

Oct 25, 2022

BUY
$224.46 - $253.15 $105,047 - $118,474
468 Added 16.44%
3,315 $747,000
Q2 2022

Jul 25, 2022

BUY
$230.71 - $256.74 $87,208 - $97,047
378 Added 15.31%
2,847 $693,000
Q1 2022

Apr 26, 2022

BUY
$219.27 - $242.57 $190,545 - $210,793
869 Added 54.31%
2,469 $597,000
Q4 2021

Jan 12, 2022

BUY
$198.88 - $227.6 $32,019 - $36,643
161 Added 11.19%
1,600 $360,000
Q3 2021

Oct 12, 2021

BUY
$212.27 - $248.7 $16,981 - $19,896
80 Added 5.89%
1,439 $306,000
Q2 2021

Jul 21, 2021

BUY
$233.58 - $259.14 $317,435 - $352,171
1,359 New
1,359 $331,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Heartwood Wealth Advisors LLC Portfolio

Follow Heartwood Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heartwood Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Heartwood Wealth Advisors LLC with notifications on news.